ADMA Biologics share price logo

ADMA Biologics

NASDAQ: ADMA

Mid Cap

$9.51

+0.40

(+4.34%)

as on

ADMA Biologics Stock Performance

as on September 22, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $9.10
    $9.54
    downward going graph

    4.31%

    Downside

    0.32%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $7.21
    $20.46
    downward going graph

    24.18%

    Downside

    115.12%

    Upside

    downward going graph

ADMA Biologics share price movements today

Previous Close
$9.11
Open
$9.17
Volume
2.6M
Market Cap
$2.0B
Day's Low - High
$9.10 - $9.54
52 Week Low - High
$7.21 - $20.46

ADMA Biologics Historical Returns

1 Month Return
-7.42 %
3 Month Return
+ 9.63 %
1 Year Return
-42.74 %
3 Year Return
+ 155.9 %
5 Year Return
+ 628.8 %

ADMA Biologics Stock Fundamentals & Key Indicators

Check ADMA Biologics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.0B

EPS (TTM)

0.72

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.14%

PE Ratio (TTM)

11.96

Industry PE ratio

-13.56

PEG Ratio

-0.6935833333333328

EBITDA

234.8M

Revenue (TTM)

512.3M

Profit Margin

64.71%

Return On Equity TTM

39.59%

ADMA Biologics Stock Valuation

Track how ADMA Biologics P/E has moved over time to understand its valuation trends.

ADMA Biologics in the last 5 years

  • Overview

  • Trends

Lowest (-35.85x)

December 31, 2023

Industry (-13.56x)

December 31, 2025

Today (29.42x)

December 31, 2025

Highest (29.42x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: 29.42x

ADMA Biologics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ADMA Biologics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
ADMA Biologics image
ADMA Biologics
Buy$2.0B628.8%11.9664.71%0.00%
Moderna image
Moderna
Neutral$61.5B-64.51%-19.3-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$130.1B174.21%29.8186.04%0.00%
Regeneron image
Regeneron
Buy$80.8B21.32%18.4884.86%0.47%

Stock Returns calculator for ADMA Biologics Stock including INR - Dollar returns

The ADMA Biologics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

ADMA Biologics investment value today

Current value as on today

₹64,852

Returns

-₹35,148

(-35.15%)

Returns from ADMA Biologics Stock

-₹40,226 (-40.23%)

Dollar Impact

₹5,078 (+5.08%)

Analyst Recommendation on ADMA Biologics Stock

Based on 3 analysts

BUY

66.67%

Buy

33.33%

Hold

0.00%

Sell

Based on 3 analysts, 66.66666666666666% of analysts recommend a 'BUY' rating for ADMA Biologics. Average target price of $17

ADMA Biologics Share Price Target

Get share price movements and forecasts by analysts on ADMA Biologics.

What analysts predicted

44.06%UPSIDE

Target Price

$17

Current Price

$9.51

Analyzed by

3 Analysts

Target

$17.00

ADMA Biologics target price $17, a slight upside of 44.06% compared to current price of $9.51. According to 3 analysts rating.

Indian Investors' Interest in ADMA Biologics Stock

Search interest for ADMA Biologics Stock has decreased by -30% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-30% versus previous 30 day period

ADMA Biologics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
81
107
119
117
114
121
134
139
114
124
Gross Profit
39
57
59
63
61
67
75
88
80
86
Operating Income
21
39
39
38
34
42
51
62
50
52
EBITDA
24
41
42
39
37
43
51
65
61
57
Interest Expense
3
3
3
2
1
1
1
1
2
3
Depreciation
2
2
1
1
1
2
2
2
1
3
Income Before Tax
18
35
36
34
33
40
47
61
57
50
Income Tax Expense
0
3
0
-77
6
5
11
12
11
12
Net Income
17
32
35
111
26
34
36
49
45
37
Net Profit Margin
47.77%
53.60%
49.78%
53.88%
53.22%
55.11%
56.34%
63.82%
70.53%
69.36%

ADMA Biologics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
22
16
29
42
80
154
258
426
510
Gross Profit
-6
-25
-10
-19
1
35
88
219
292
Operating Income
-39
-60
-41
-64
-58
-39
21
138
191
EBITDA
-39
-56
-36
-59
-53
-39
5
147
197
Interest Expense
3
5
8
11
13
19
25
13
7
Depreciation
1
3
3
3
5
7
8
8
8
Income Before Tax
-43
-65
-48
-75
-71
-65
-28
125
182
Income Tax Expense
-
-
-
-
-
-
-
-71
35
Net Income
-43
-65
-48
-75
-71
-65
-28
197
146
Net Profit Margin
-28.14%
-148.42%
-34.60%
-45.17%
1.45%
22.89%
34.44%
51.48%
57.39%

ADMA Biologics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
17
32
35
111
26
34
36
49
45
37
Operating Cash Flow
-2
45
25
50
-19
21
13
35
58
29
Investing Cash Flow
-2
-2
-1
-2
-4
-2
-14
0
2
-2
Financing Cash Flow
-1
0
-25
-31
-7
0
-27
-9
-10
-29
Change in Cash
-6
42
-1
16
-31
18
-28
26
50
-2

ADMA Biologics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-43
-65
-48
-75
-71
-65
-28
197
146
Operating Cash Flow
-37
-62
-76
-102
-112
-59
8
118
50
Investing Cash Flow
15
-2
-3
-12
-13
-13
-4
-8
-21
Financing Cash Flow
60
42
80
143
121
108
-38
-58
-44
Change in Cash
38
-21
0
29
-4
35
-35
51
-15

Mutual Funds that own ADMA Biologics Stock

Check out the Mutual Funds with significant holdings in ADMA Biologics.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
6.240368%
13977470
SMALLCAP World Fund Inc
4.411013%
9879994
TIAA-CREF Funds
1.857902%
4161416
American Century Mutual Funds, Inc.
1.50183%
3363870
Fidelity Salem Street Trust
1.118479%
2505222
See all

Global Institutional Holdings in ADMA Biologics

Funds
Holdings
iShares
12.62%
Vanguard
7.67%
SPDR
5.58%
First Trust
4.48%
Xtrackers
1.1%
See all

ADMA Biologics News & Key Events

  • img

    Today's Timeline - 24 March

    Tue, 08:01 PM

    -

    ADMA Biologics' 2026 EPS estimates increased from 85 cents to 96 cents, but shares have lost 11.3% over six months.

Insights on ADMA Biologics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ADMA stock has moved up by 10.4%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 114.49M → 124.39M (in $), with an average increase of 8.0% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ADMA has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 551.1% return, outperforming this stock by 591.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 49.37M → 37.82M (in $), with an average decrease of 12.4% per quarter

About ADMA Biologics

ADMA Biologics, Inc. functions as a biopharmaceutical company specializing in the development, manufacturing, and commercialization of advanced biologic therapies derived from blood plasma. These specialized products are engineered to address immune system disorders and infectious diseases, catering to markets across the United States and internationally. Their current product portfolio includes BIVIGAM and ASCENIV, both intravenous immune globulin (IVIG) treatments prescribed for primary humoral immunodeficiency (PI). Additionally, the company offers Nabi-HB, utilized for immediate treatment following acute exposure to the Hepatitis B virus and other specified exposures. Beyond its existing offerings, ADMA is actively developing a pipeline of new plasma-derived therapeutics. This includes immunoglobulin products specifically targeting the prevention and treatment of S. pneumonia infections. The company also oversees its own facilities for source plasma collection. Product distribution is managed through a comprehensive network involving independent distributors, sales agents, specialty pharmacies, and other alternative healthcare providers. ADMA Biologics, Inc. was founded in 2004 and maintains its corporate headquarters in Ramsey, New Jersey.
OrganisationADMA Biologics
Headquarters465 State Route 17, Ramsey, NJ, 07446, US
IndustryBiotechnology
CEOAdam S. Grossman
E-voting on sharesClick here to vote

Key Management of ADMA Biologics

Name

Title

Mr. Adam S. Grossman

Co-Founder, President, CEO & Director

Dr. Jerrold B. Grossman D.P.S., Ph.D.

Co-Founder & Vice Chairman of the Board

Mr. P. Terence Kohler

CFO & Treasurer

Ms. Kaitlin M. Kestenberg

COO & Senior VP of Compliance

Mr. Michael Goldstein

General Counsel

Mr. John Hafl

Executive Director of Sales

Mr. Skyler Bloom

Senior Director of Business Development & Corporate Strategy

FAQs

What is ADMA Biologics share price today?

ADMA Biologics share price today is $9.51 as on at the close of the market. ADMA Biologics share today touched a day high of $9.54 and a low of $9.10.

What is the 52 week high and 52 week low for ADMA Biologics share?

ADMA Biologics share touched a 52 week high of $20.46 on and a 52 week low of $7.21 on . ADMA Biologics stock price today i.e. is closed at $9.51,which is 53.51% down from its 52 week high and 31.90% up from its 52 week low.

What is ADMA Biologics's market capitalisation today?

ADMA Biologics market capitalisation is $0.00T as on .

How to invest in ADMA Biologics Stock (ADMA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for ADMA Biologics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ADMA Biologics Shares that will get you 0.1577 shares as per ADMA Biologics share price of $9.51 per share as on September 22, 2026 at 8:46 am IST.

What is the minimum amount required to buy ADMA Biologics Stock (ADMA) from India?

Indian investors can start investing in ADMA Biologics (ADMA) shares with as little as ₹95.805 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.05 in ADMA Biologics stock (as per the Rupee-Dollar exchange rate as on ). Based on ADMA Biologics share’s latest price of $9.51 as on September 22, 2026 at 8:46 am IST, you will get 1.0515 shares of ADMA Biologics. Learn more about fractional shares .

What are the returns that ADMA Biologics has given to Indian investors in the last 5 years?

ADMA Biologics stock has given 628.8% share price returns and 30.09% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?